國科微(300672.SZ):研發的AI視覺芯片可應用於機器視覺領域,並已規模落地其他多場景邊緣AI應用
格隆匯1月4日丨有投資者於投資者互動平台向國科微(300672.SZ)提問,“請問貴公司的AI視頻芯片可以應用在機器人裏面嗎?”,公司回覆稱,從類型上劃分,機器人可分為傳統機器人與人形機器人。人形機器人的核心技術包括計算機視覺、語音交互、伺服驅動器、運動規劃及控制以及定位導航等。人形機器人需利用傳感器(攝像頭、激光雷達等)感知、採集和處理周圍環境信息,從而做出決策;傳統機器人中的服務機器人同樣需具有一定的機器視覺能力。公司研發的AI視覺芯片可應用於機器視覺領域,並已規模落地其他多場景邊緣AI應用,如智慧家居、車載、智慧安防等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.